Annual securities reports (有価証券報告書) filed on EDINET — management narrative only (statistics tables, financial-statement notes, director remuneration and cross-shareholding disclosure are excluded). TSE corporate-governance reports and TDnet are separate documents and are not read here.
CHUGAI PHARMACEUTICAL CO., LTD. 4519
| Cost of capital | uses the term as a comparator 「個別の開発テーマ等の投資判断におきましては、資本コストを踏まえた投資価値評価を行い」BusinessPolicyBusinessEnvironmentIssuesToAddressEtcTextBlock | read (2026-09-01) |
|---|---|---|
| PBR | no mention | matched by rule |
| Metric | names a metric 「長期にわたる投資効率の指標としてCoreROICを重点的に管理するとともに、短中期的にも安定的な利益成長を達成できるよう、機動的で柔軟な事業運営に努めています」BusinessPolicyBusinessEnvironmentIssuesToAddressEtcTextBlock | matched by rule |
| Target | target without a date 「また、長期にわたる投資効率の指標として重点的に管理しているCoreROIC*の実績は、税引後営業利益の増加により43.9%(前年比1.0%ポイント増)となりました」ManagementAnalysisOfFinancialPositionOperatingResultsAndCashFlowsTextBlock | matched by rule |
| Payout | states a numeric policy | matched by rule |
For desks: your watchlist through these questions, kept current each filing season. Custom, from $999+.
Reply with your names